In summary, the precedent of a 12 month PCV booster for Indigenous children in WA and QLD, and the high incidence of IPD and OM in the first half of the second year of life support the decision to choose a 13 month booster for this study. The mixed schedules will still allow us to compare boost versus no boost for HiD, 3,6A and 19A.